Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the U.S. Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.
Patient Care
Advances in Targeted Therapy for Breast Cancer
Fed Pract. 2015 May;32(suppl 4):46S-49S
Author and Disclosure Information
Dr. Mener is a fellow in hematology/oncology and Dr. Aggarwal is an associate professor of medicine, both at The George Washington University in Washington, DC. Dr. Aggarwal is also an associate professor of medicine at Georgetown University and a hematologist/oncologist at the Washington DC VAMC, both in Washington, DC. She is also president elect of Association of VA Hematology and Oncology.
Next Article:
Clinical Topics
-
Is early-onset cancer an emerging global epidemic? -
Cost paramount when choosing metastatic breast cancer treatment Publish date: September 30, 2022 -
Genetic tests create treatment opportunities and confusion for breast cancer patients Publish date: September 22, 2022 -
Time to cancer diagnoses in U.S. averages 5 months Publish date: September 15, 2022 -
Single Institution Retrospective Review of Patterns of Care and Disease Presentation in Female Veterans With Breast Cancer During the COVID-19 Pandemic
Digital Edition
-
Cancer Data Trends 2023 Publish date: July 5, 2023 -
Cancer Data Trends 2022 Publish date: March 30, 2022 -
AVAHO 2021 Meeting Posters and Abstracts Publish date: September 22, 2021 -
Advances in Hematology and Oncology Publish date: September 3, 2021 -
Advances in Hematology and Oncology Publish date: May 20, 2021
Multimedia
-
Data underscore the importance of lifestyle interventions in breast cancer patients Publish date: December 17, 2018 -
Extended AI therapy reduces breast cancer recurrence risk, ups fracture risk Publish date: December 14, 2018 -
Extending Therapy for Breast Cancer Publish date: September 3, 2014
Conference Coverage
-
Particulate pollution increases the risk for breast cancer Publish date: November 9, 2023 -
Dato-DXd trumps chemo in advanced HR+/HER2– breast cancer Publish date: October 25, 2023 -
The sobering facts about alcohol and cancer Publish date: October 25, 2023 -
ICIs improve pCR rates in early ER+/HER2– breast cancer Publish date: October 22, 2023 -
No benefit to adding ICI to chemo in triple-negative breast cancer: study Publish date: October 22, 2023 -
Remote symptom monitoring in advanced cancer improves quality of life Publish date: October 22, 2023 -
Fasting during breast cancer chemo improves quality of life Publish date: October 22, 2023 -
Adjuvant abemaciclib-ET combo shows long-term benefit in high-risk early breast cancer Publish date: October 20, 2023 -
Adopting high-dose radiation vs. conventional after mastectomy could be ‘game changer’ Publish date: October 4, 2023 -
Multiprong strategy makes clinical trials less White Publish date: June 23, 2023
Factors related to breast cancer surgery choices
Question 1 of 5